Results 91 to 100 of about 1,041,956 (191)

Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis. [PDF]

BMJ Case Rep, 2023
Acharya I, Weisman DS, Smith LW, Arend LJ.   +3 more
europepmc   +1 more source

Pulmonary pattern in systemic vasculitis: granulomatosis, lung cancer or both? [PDF]

Reumatologia, 2022
Smiyan S, Bernstein Z, Izhik A, Sokolov V, Dyadyk O, Gusak S, Rozumnyi O, Symko H, Komorovsky R.   +8 more
europepmc   +1 more source

The challenge of ocular inflammation in systemic vasculitis: How to address inequalities of care? [PDF]

Rheumatol Immunol Res, 2023
Ghadiri N, Nair J, Moots RJ.
europepmc   +1 more source

Axillary lymphadenopathy as the initial manifestation in ANCA-associated systemic vasculitis: A case report. [PDF]

Medicine (Baltimore), 2023
Du J, Wang H, Zhang L, Li H, Li S, Zhang C, Sun F, Zhao L.   +7 more
europepmc   +1 more source

Case report: Mononeuropathy multiplex of extranodal natural killer/T-cell lymphoma misdiagnosed as systemic vasculitis. [PDF]

Front Neurol, 2023
Shi J, Niu J, Wu D, Zhang L, Huang Y, Zhang H, Guan H, Liu M, Guan Y.   +8 more
europepmc   +1 more source

Cyclophosphamide and systemic vasculitis

QJM: An International Journal of Medicine, 1993
Luqmani, R, Moots, R, Emery, P, Bacon, P, Adu, D   +4 more
openaire   +2 more sources

Obinutuzumab in Rituximab-Intolerant Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Patients

Kidney International Reports
Jolijn R. van Leeuwen, Obbo W. Bredewold, Ton J. Rabelink, Y.K.Onno Teng   +3 more
doaj   +1 more source

Improving patient outcomes in systemic vasculitis

, 2016
The systemic vasculitides are a group of rare heterogeneous conditions where the primary problem is inflammation of blood vessels. The underlying aetiology for most forms of vasculitis is unknown.
Suppiah, Ravi
core  

The Expression of High Mobility Group Box-1 (HMG1) in the Peripheral Blood and Its Relation with Systemic Vasculitis Patients. [PDF]

Iran J Public Health, 2023
Qin Y, Li X, Shi L, Liu Y, Wang Z, Guan Y.   +5 more
europepmc   +1 more source

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy

Kidney International Reports
Mieke van Schaik, Aiko P.J. de Vries, Frederike J. Bemelman, Ton J. Rabelink, Leendert A. Trouw, Cees van Kooten, Yoe Kie Onno Teng   +6 more
doaj   +1 more source